Sergliflozin etabonate

SKU: orb1699324

Description

Sergliflozin etabonate (KGT-1251) is a selective SGLT2 inhibitor for research on type 2 diabetes and obesity. It has demonstrated efficacy in reducing hyperglycemia and body weight in rodent models, making it a tool for in vivo metabolic studies.

Research Area

Pharmacology & Drug Discovery

Key Properties

• CAS Number: 408504-26-7
• MW: 448.46
• Purity: 97.88% (May vary between batches)
• Formula: C₂₃H₂₈O₉
• SMILES: O(C1=C(CC2=CC=C(OC)C=C2)C=CC=C1)[C@@H]3O[C@H](COC(OCC)=O)[C@@H](O)[C@H](O)[C@H]3O
• Target: SGLT
• Solubility: DMSO:50 mg/mL (111.49 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (11.15 mM)

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

KGT 1251, GW 869682, GW 869682X, GW869682, GW869682X, GW-869682X, SGLT2, Sergliflozin etabonate

Compound Identifiers

PubChem CID

9824918